Literature DB >> 11580205

Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease.

S Inoue1.   

Abstract

High-resolution ultrastructural and immunohistochemical studies revealed that in situ beta amyloid fibrils of Alzheimer's disease were made up of a core consisting of a solid column of amyloid P component (AP) and associated chondroitin sulfate proteoglycan, and a heparan sulfate proteoglycan surface layer with externally associated fine filaments of beta protein. The main body of beta amyloid fibrils closely resembled that of microfibrils. Abundant microfibrils were reported to be present at the basement membrane of capillaries with "leaky" blood-urine or blood-air barriers. Similarly, abundant microfibril-like beta amyloid fibrils are formed at the microvascular basement membrane in cerebrovascular amyloid angiopathy with altered blood-brain barrier. Since AP is an indispensable major component of microfibrils and microfibril-like structures, the formation of microfibrils may depend on, among other factors, the availability of AP. Thus, in beta amyloid fibrillogenesis fibrils may be built around AP which continuously leaks out from circulation into vascular basement membrane, and beta amyloid fibrils may be regarded as pathologically altered basement membrane-associated microfibrils. With no source of AP around them, senile plaque fibrils may also be derived from perivascular amyloid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580205     DOI: 10.1016/s0074-7696(01)10005-7

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  8 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.

Authors:  Fanling Meng; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-12-30       Impact factor: 5.469

Review 3.  A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides.

Authors:  Andisheh Abedini; Daniel P Raleigh
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

4.  Early pathogenesis of cardiac amyloid deposition in senile systemic amyloidosis: close relationship between amyloid deposits and the basement membranes of myocardial cells.

Authors:  Motoji Sawabe; Akihiko Hamamatsu; Tateki Ito; Tomio Arai; Kumiko Ishikawa; Kouji Chida; Naotaka Izumiyama; Naoko Honma; Kaiyo Takubo; Masamitsu Nakazato
Journal:  Virchows Arch       Date:  2003-02-26       Impact factor: 4.064

5.  Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.

Authors:  Hui Wang; Ping Cao; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2012-11-12       Impact factor: 5.469

6.  A role for helical intermediates in amyloid formation by natively unfolded polypeptides?

Authors:  Andisheh Abedini; Daniel P Raleigh
Journal:  Phys Biol       Date:  2009-02-10       Impact factor: 2.583

7.  The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.

Authors:  Hui Wang; Daniel P Raleigh
Journal:  Biochemistry       Date:  2014-04-18       Impact factor: 3.162

Review 8.  The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.

Authors:  Clara Iannuzzi; Gaetano Irace; Ivana Sirangelo
Journal:  Molecules       Date:  2015-02-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.